The mouse cyritestin gene is a member of the ADAM (a disintegrin and metalloprotease) gene family and codes for a membrane-anchored sperm protein. Recently, it was shown that cyritestin is critical for male fertility in the mouse. Spermatozoa of cyritestin-deficient mice are not able to bind to the zona pellucida of the oocyte and therefore unable to fertilize the egg. However, zona-free oocytes can be fertilized and the resulting embryos show normal development. In contrast to the mouse, where only one gene for cyritestin (Cyrn) is reported, two cyritestin genes (CYRN1 and CYRN2) are known in humans. The human CYRN1 and CYRN2 genes are located on chromosomes 8 and 16, respectively. We report that 27 % of fertile men are deficient for the CYRN1 gene but that all have a CYRN2
INTRODUCTION
Genes belonging to the ADAM (a disintegrin and metalloprotease) family were suggested to be involved in spermegg binding and fusion [1, 2] . All members of this protein family contain characteristic features like a signal peptide, prodomain, metalloprotease-like domain, disintegrin domain, cysteine-rich domain, epidermal-growth-factor-like repeat, and transmembrane and cytoplasmatic domains in their prepropeptide [3] [4] [5] . The presence of the disintegrin domain similar to that of soluble snake venom toxins led to the suggestion that members of the ADAM family are involved in cell-cell adhesion through binding to integrins. Fertilin, a member of the ADAM family, is known to play an important role in binding and\or fusion between sperm and the egg plasma membrane [3, [6] [7] [8] [9] [10] .
Cyritestin, another member of the ADAM family, also known as ADAM 3 or tMDC1, is the product of the Cyrn gene, which is localized on mouse chromosome 8 [11] . The gene is specifically expressed in male germ cells [4] . Whereas the transcription of the mouse Cyrn gene is detectable in the testis at postnatal day 14, the protein is first demonstrated at postnatal day 18 [12] . Experiments using anti-cyritestin antibodies have demonstrated that cyritestin is localized in the acrosomal region of spermatids and spermatozoa and undergoes post-translational modification during sperm passage through the epididymis [12] . The results of in itro-fertilization experiments, using a peptide corresponding to the disintegrin domain of cyritestin, suggested that cyritestin is one of the major components of sperm-egg fusion events at the level of the egg membrane [13, 14] . Cyritestin-deficient male mice were found to be infertile. Experiments in itro revealed that the infertility is due to the inability of the cyritestin-deficient sperm to bind to the zona pellucida, whereas the binding and fertilization of these spermatozoa to zona-free oocytes were normal [15] .
Abbreviations used : ADAM, a disintegrin and metalloprotease ; RT-PCR, reverse transcriptase PCR ; THEG, testicular haploid expressed gene. 1 To whom correspondence should be addressed (e-mail wengel!gwdg.de). The nucleotide sequence data reported in this paper appear in the GenBank and EMBL Nucleotide Sequence Databases under the accession number AF 334867.
gene, suggesting that the CYRN2 gene is the orthologous mouse cyritestin gene in humans and might be involved in sperm-egg interactions. However, the characterization of CYRN2 transcripts from testicular RNA of CYRN1-deficient men demonstrated many termination codons in the synthesized cyritestin cDNA. Furthermore, Western-blot analysis with human testicular protein extracts using an anti-cyritestin antibody failed to detect any cyritestin protein. These results demonstrate clearly that both cyritestin genes are non-functional in humans.
Key words : deletion inheritance, male infertility, sperm-egg interaction, testicular expression.
In contrast to the mouse, the human genome contains two cyritestin genes, CYRN1 and CYRN2, which are localized on chromosome 8p12-21 and 16q12, respectively [16, 17] . Both genes were found to be expressed only in the testis [16] . A Western-blot analysis using rabbit antisera against human and macaque CYRN1 peptide revealed no immunoreactivity with human testis and sperm extracts. The presence of a variety of deletions, insertions and in-frame termination codons led the authors to suggest that the CYRN1 gene is non-functional in humans [18] . Our Southern-blot analysis revealed that in some individuals the CYRN1 gene is deleted. This finding led us to screen for this deletion in men and to repeat the Western-blot analysis, because we could not exclude the possibility that the protein extracts used by Frayne and Hall [18] were taken from a man with a CYRN1 deletion. We have analysed both fertile and infertile men. The CYRN1 deletion was found in both groups with the same frequency, which suggests that this mutation has no relevance for fertility. Furthermore, the deletion of the CYRN1 gene in fertile men suggests that the CYRN1 gene is non-functional in humans. However, all probands have been found to be endowed with the CYRN2 gene in their genome, suggesting that the CYRN2 gene is functional and might replace the non-functional CYRN1 gene. However, our Western-blot investigations revealed that the CYRN2 gene is also non-functional in humans. These results indicate that, in humans, another yet unknown gene could replace the function of cyritestin in sperm-egg interactions.
MATERIALS AND METHODS

Probands
Blood samples from 120 men with proven fertility (co-workers and probands) were used for DNA isolation. Testis material was obtained from 50 postmortem men, for which histological analyses showed normal spermatogenesis. The testis tissue was used for DNA, RNA and protein isolation. Blood samples from 12 infertile men whose spermatozoa showed an inability to bind and to fuse with oocytes in in itro-fertilization assays were used for DNA isolation. Blood samples from eight females (coworkers) were used for DNA isolation. Kidney tissue was obtained from a postmortem man and used for protein isolation. Macaque testis tissue was obtained from the Deutsches Primaten Zentrum (DPZ) in Go$ ttingen, Germany, and used for protein isolation.
Generation of DNA probes for Southern-blot analysis
Human cyritestin 1 cDNA clone T6 (accession number X89657) was digested with EcoRI and PstI enzymes. Two fragments were isolated as CYRN1-specific probes : a 574 bp-long fragment from the 5h region of the cDNA sequence (positions 312-886) and a 884 bp fragment from the 3h end (positions 1751-2635), called T6B and T6A, respectively ( Figure 1A ). These fragments were subcloned, sequenced and used for Southern-blot experiments. A CYRN2-specific probe, AH, was generated by PCR using cosF (5h-CACTGGACACATTCAGAAACAG-3h) and cosR (5h-TC-ATTGTTAGATCAGGCCAGTT-3h) primers and CYRN2 genomic clone (4kb-Hd, accession number Y10615) as a template ( Figure 1B ). PCR products were subcloned into the pGEM-T vector (Promega, Southampton, U.K.) and sequenced.
Southern-blot analysis
High-molecular-mass human genomic DNA was isolated using standard methods. DNA (20 µg) was digested with HindIII restriction enzyme, fractionated on 1 % agarose gel and transferred to Hybond C membrane. Probes were labelled with $#P using the Rediprime II labelling system (Amersham, Braunschweig, Germany) according to the manufacturer's instructions. The membrane was hybridized at 65 mC in Membrane Hybridization Buffer (KPL) and washed with the following stringency : 20 min in 2iSSC buffer at room temperature, 10 min in 2iSSC\0.1 % SDS at 65 mC and 10 min in 0.2iSSC at 65 mC (where 1iSSC is 0.15 M NaCl\0.015 M sodium citrate).
Reverse transcriptase PCR (RT-PCR)
Total RNA from human testes was isolated using the Rneasy mini kit (Qiagen, Hilden, Germany) according to the manual supplied. For RT-PCR, RNA (5 µg) was annealed with oligodT "( primer. The cDNA was synthesized using 200 units of Superscript reverse transcriptase (Life Technologies, Karlsruhe, Germany) at 42 mC for 50 min. PCR was carried out with 5 µl of synthesized cDNA, 10 pmol of reverse and forward primers and 3 units of Taq polymerase (Life Technologies). CYRN1 expression was analysed by RT-PCR using IS1 (5h-GTTACTGT-CCAGGAACTACATGC-3h) and IS6 (5h-ACTGTGAACACT-GTCTATCCC-3h), CYRN1-specific primers, and the cycling conditions were 2 min at 94 mC followed by 30 cycles of 1 min at 94 mC, 1 min at 60 mC and 2 min at 72 mC.
For the study of the CYRN2 expression, cosF-and cosRspecific primers were used. Cycling conditions were 4 min at 94 mC, then 35 cycles of 1 min at 94 mC, 1 min at 65 mC and 2 min at 72 mC, and ending with 5 min at 72 mC. The PCR products were electrophoresed in 1.5 % agarose gel. To see whether the obtained PCR products in fact belong to the CYRN2 gene, the amplification products were extracted from the gel, subcloned into pGEM-T vector (Promega) and sequenced on both strands. The integrity of the RNA samples was checked by RT-PCR for 5 S rRNA using primers and conditions as described in [19] .
Western-blot analysis of human cyritestin
Anti-CYRN antisera were produced by Eurogentec (Seraing, Belgium) using the synthetic peptide CLSAHARNGSKQ derived from the putative cysteine-rich domain of human CYRN1 and CYRN2, conjugated to the keyhole-limpet haemocyanin protein.
The polyclonal antiserum was affinity purified using HiTrap Nhydroxysuccinimide-activated Sepharose columns according to the manufacturer's instructions (Amersham). Proteins were extracted from human testis, human kidney and macaque testis by homogenization in lysis buffer (150 mM NaCl, 10 mM EDTA, 50 mM Tris\HCl, pH 7.6, 1 % Triton X-100 and 1 % sodium deoxycholate) containing protease inhibitors (1 µg\µl leupeptin\3 µg\µl aprotinin). Lysates were sonicated and centrifuged at 7000 g for 10 min at room temperature, and supernatants were collected. Proteins (100 µg\lane) were separated by electrophoresis in a 10 % polyacrylamide gel and electroblotted on PVDF membranes (Macherey and Nagel, Du$ ren, Germany). Blots were incubated overnight with anti-CYRN antibodies at 4 mC. After extensive washing, blots were incubated for 1 h at room temperature with anti-rabbit IgG conjugated with alkaline phosphatase (Sigma, Duisenhofen, Germany). The detection of bound antibodies was achieved by colour reaction with 18.8 mg\ml Nitro Blue Tetrazolium chloride (NBT) and 9.4 mg\ml 5-bromo-4-chloro-3-indolylphosphate toluidine salt (BCPIP) in 67 % DMSO. The protein quality was checked by incubation with a monoclonal anti-α-tubulin antibody (Sigma) [20] .
Database searches and sequence analysis
The GenBank database was searched for genomic sequences of human cyritestin using the advanced BLAST program [21] at the National Center for Biotechnology Information home page (http :\\www.ncbi.nlm.nih.gov\blast). One human clone was identified, RP11-189E14, localized on chromosome 16 (working drafting sequence, locus AC007861). The CYRN2 gene corresponds to nucleotides 155128-156067 in this clone.
RESULTS
Deletion of the CYRN1 gene is not associated with male infertility
In HindIII-digested genomic DNA, the CYRN1 5h probe (T6B, Figure 1A ) detected a 10 kb fragment (Figure 2A) , whereas a 4 kb fragment was observed ( Figure 2C ) using the CYRN2 probe (AH, Figure 1B) . Southern-blot analyses of DNA from 12 infertile men, whose spermatozoa showed an inability to bind and to fuse with oocytes in in itro-fertilization assays, revealed that the 5h probe of CYRN1 did not detect the 10 kb HindIII fragment in the genomes of three of these men. To investigate whether only the 5h region or the complete CYRN1 gene was deleted, the T6A probe ( Figure 1A ) corresponding to the 3h end of the cDNA was used to rehybridize the Southern blots. The 3h probe of CYRN1 cDNA detected a 7.5 kb HindIII fragment ( Figure 2B ) only in the genomes of those with a CYRN1-positive genotype. These results demonstrate that the complete CYRN1 locus was deleted in the three infertile men. To address the question of whether the deletion of CYRN1 is associated with male infertility, we have genotyped fertile men and women for the deletion of the CYRN1 gene. Of 120 men, 27 % were classified as CYRN1-deficient, and 73 % as CYRN1-positive. The CYRN1 deletion was also found in two of eight females. To determine the presence of CYRN2 in the genomes of the studied cases, Southern blots were rehybridized with the CYRN2-specific probe. The 4 kb HindIII fragment of the CYRN2 gene was detected in all individuals analysed ( Figure 2C ). These data indicate that deletion of the CYRN1 gene is neither associated with male infertility nor functional in humans.
To investigate the inheritance of the CYRN1 deletion, the genomic DNA of a family with six children was analysed ( Figure  3A) . Southern-blot analysis demonstrated that the mother and
Figure 2 Southern-blot analyses of human cyritestin genes
Genomic DNA was isolated from 10 infertile men and digested with HindIII restriction enzyme. (A) Southern-blot analysis using the 5h probe (T6B) of the CYRN 1 cDNA. The 10 kb HindIII fragment was deleted in the genomes of individuals 7 and 9. (B) Probe T6A was used to demonstrate that the 3h region of the CYRN 1 gene was also deleted in the genomes of individuals 7 and 9. In individuals with the CYRN 1-positive genotype a 7.5 kb fragment was detected by the T6A probe. (C) Southern-blot analysis using the CYRN 2-specific probe AH. A 4 kb fragment was detected in all individuals analysed. two children were CYRN1-positive, whereas the father and four children were CYRN1-deficient. These results indicate that the mother is heterozygous and the father is homozygous for the CYRN1 deletion. According to the hybridization pattern with the DNA of the six children, four were homozygous and two were heterozygous for the CYRN1 deletion. To prove the DNA's quality and also the presence of the CYRN2 gene, the membrane was rehybridized with the CYRN2-specific probe. All family members were found to contain the CYRN2 gene in their genome ( Figure 3B ).
Cyritestin gene expression in men with the CYRN1 deletion
To confirm that the CYRN1 gene is completely deleted, we performed RT-PCR using testicular RNA of fertile men and CYRN1-specific primers IS1 and IS6 (Figure 4) . No CYRN1 transcripts were found in the CYRN1-deficient cases, whereas two splice variants were amplified in the testicular RNA of those with a CYRN1-positive genotype. Integrity of the RNA was analysed by RT-PCR for 5 S rRNA using primers and conditions as described in [19] (Figure 4) . The fact that the CYRN1 gene can be deleted in fertile men indicates that it is not a critical gene for male fertility in humans. To address the question of whether CYRN2 is able to replace CYRN1, testicular RNA from CYRN1-deficient men was used for amplification of CYRN2 cDNA. The expected 650 bp CYRN2 cDNA fragment was obtained ( Figure  5A ). Because both CYRN2-specific primers are located in the same exon, genomic DNA contamination of the testicular RNA was excluded. Using THEG (testicular haploid expressed gene)-specific primers, the typical two splice products (280 bp and 352 bp) for THEG cDNA were amplified, but not the PCR product of 3 kb, which is obtained with genomic DNA ( Figure  5B ) [22] .
Western-blot analysis for cyritestin
To investigate the presence of human cyritestin proteins in the testes and spermatozoa, Western-blot analysis was performed. Antibodies were generated in rabbits against a synthetic peptide containing the conserved amino acid sequence located in the cysteine-rich domains of both human CYRN1 and CYRN2. Testicular and spermatozoan protein extracts from CYRN1-positive and CYRN1-deficient men were probed with anti-CYRN antibodies. Macaque testis and human kidney protein extracts were used as positive and negative controls, respectively. An 86 kDa protein was detected in macaque testicular extract but not in extracts of human testis, spermatozoa or kidney ( Figure   Figure 5 Expression analysis of the CYRN 2 gene 5) were probed with anti-CYRN antibodies. CYRN protein bands could not be detected in human protein extracts ; however, an 86 kDa protein band was observed in protein extract from macaque testis tissue. Loaded protein amounts were determined using monoclonal anti-α-tubulin antibodies (α-Tub). M, molecular-mass standard.
6). Protein quality and integrity was analysed by incubation of the blot with anti-α-tubulin antibody.
Sequence analysis of the CYRN2 gene
The amplified cDNA fragment (AH) of the CYRN2 gene as well as the genomic clone 4kb-Hd ( Figure 1B) were sequenced. To get more sequence information about the CYRN2 gene, the 700 bp cDNA sequence (accession number Y10615) was aligned with the human genome database using the search tool BLAST. This comparison revealed 100 % identity with one genomic clone (accession number AC007861) located on chromosome 16, corresponding to the chromosomal localization of the CYRN2 gene [16] . Analysis of both the CYRN2 cDNA and the corresponding genomic sequences revealed many stop codons in all possible reading frames. Although the amino acid sequences between the stop codons showed high similarity with the macaque cyritestin protein [23] , it is very unlikely that this gene could produce a functional protein in humans.
DISCUSSION
The mouse is endowed with one cyritestin gene on chromosome 8 [11] . Mice that are deficient for cyritestin were found to be infertile due to the inability of their spermatozoa to bind to the zona pellucida of the oocyte [15] . Therefore it was suggested that a human orthologous gene could play a role in sperm-egg interaction. In the human genome two cyritestin genes are present, CYRN1 and CYRN2. Frayne and Hall [18] reported the results of Western-blot analysis with human testicular protein and an anti-CYRN1 antibody. They found that no CYRN1 protein is demonstrable in human testis, although a positive result was obtained with proteins from macaque testis. From these results the authors concluded that the CYRN1 gene (also called tMDC1) is non-functional in humans [18] . Our data support this conclusion.
The results of our screening study for the CYRN1 gene in fertile individuals demonstrate a large deletion in the locus for CYRN1 on human chromosome 8. Of the 120 individuals tested, 32 (27 %) had a deletion in CYRN1 gene. A study of the inheritance of the CYRN1 deletion in a family with six children clearly demonstrated Mendelian inheritance. At the transcrip-tional level it was found that in testicular RNA of fertile men with the CYRN1 gene deletion no CYRN1 transcript could be detected by RT-PCR. Thus, it was shown that the CYRN1 gene has no function in human male fertility.
As stated, in the human genome a second cyritestin gene (CYRN2) is present on chromosome 16. Therefore, we suggested that this gene could be the orthologous human gene to the mouse cyritestin gene, whose inactivation results in male infertility in mice [15] . This hypothesis was supported by the observation that the DNA of all individuals lacking the CYRN1 gene showed hybridization signals in Southern-blot analysis with a CYRN2-specific probe. Testicular RNA from men with the CYRN1 deletion was used for amplification with CYRN2-specific primers, and RT-PCR products were obtained. This result led us to suggest that the CYRN2 gene is the orthologous human gene to the mouse cyritestin gene and therefore of importance for male fertility. Therefore, the expression of the CYRN2 gene was studied in human testis. The RNA from individuals with the CYRN1 gene deletion was taken for amplification with CYRN2-specific primers and the transcript was found in all individuals tested. This result supported the hypothesis that CYRN2 can replace the CYRN1 gene in its function.
The sequencing of the CYRN2 RT-PCR product resulted in some single-base-pair differences when compared with the published sequence of a subcloned genomic fragment (4kb-Hd) [16] but was found to be identical to a genomic sequence of the CYRN2 gene on chromosome 16 in the human genome database. To obtain more information about the cDNA and the genomic structure of the CYRN2 gene, the cDNA sequence of the CYRN1 gene was compared with the sequence of CYRN2 in the human genome database. An additional 233 bp was found that shared 87 % identity with the CYRN1 cDNA in the 5h direction. The deduced amino acid sequence was found to contain the cysteinerich, epidermal-growth-factor-like and transmembrane domains of a typical cyritestin protein, but not the disintegrin and metalloprotease domains. Since the working draft sequence clone for CYRN2 is not yet completed and the known sequence of the genomic clone 5h from our cDNA is 22 kb, we cannot exclude the possibility that the missing disintegrin and metalloprotease domains are localized in sequence 5h of the 22 kb region, which might be an intron. Most importantly, the known CYRN2 cDNA was found to contain many stop codons in all three possible reading frames. This result indicates that the CYRN2 gene in humans does not code for a functional protein. This is supported by the results of a Western-blot analysis. Our antibody, which was generated against sequences identical in putative CYRN1 and CYRN2 proteins, gave no staining with testicular proteins of individuals lacking the CYRN1 gene but which were endowed with the CYRN2 gene. Because the peptide used for raising the antisera includes a potential N-glycosylation sequence, it cannot be excluded that the antisera did not recognize the respective epitope. However, this possibility is rather unlikely because the antisera detected the macaque cyritestin protein ( Figure 6 ).
Taking together all results obtained for the cyritestin genes, it is clear that, in contrast to the mouse, in humans the cyritestin genes are non-functional. Concerning the members of the ADAM gene family, this observation with the cyritestin genes is not unique. In the mouse, fertilin-α is important for sperm-egg binding [23, 24] , whereas this gene in the human is non-functional and possibly replaced in terms of function by ADAM 20. In the case of cyritestin we have no indication as to which other ADAM gene could replace it. It is also possible that in the human genome a third cyritestin gene exists, but all searches in the human GenBank database were negative.
The results of Frayne and Hall [18] and those reported here are important for the relevance of results obtained in the mouse with respect to our understanding of fertilization in humans. Results obtained from mice in this field, even from knockout mice, can now hardly be assigned to the fertilization process in humans.
